Highly exuding wounds are challenging to treat. That is why we are providing a wound healing solution that clinicians want to see and that patients can feel.
Read news and updates about our company.
Mölnlycke News
May 31, 2024
EUR bond issue and tender announcement
Mölnlycke intends to issue a new 10-year EUR bond and launches a tender offer for the outstanding EUR 500m bond due February 2025.
June 5, 2024
Mölnlycke successfully prices a EUR 500M bond maturing 2034
Gothenburg, 4 June 2024: Mölnlycke, a world-leading MedTech company, has successfully raised EUR 500M in the corporate bond market under its Euro Medium...
uncategorized
May 15, 2024
Mölnlycke Health Care expands investment in Tamer Mölnlycke Care joint venture
Mölnlycke Health Care, a world leading MedTech company, has expanded its commitment to operations in the Middle East by extending its stake from 33.3% t...
May 17, 2024
Mölnlycke announces new partnership with burn survivors organisation Phoenix Society
Mölnlycke Health Care is pleased to announce our partnership with Phoenix Society for Burn Survivors.
April 12, 2024
Mölnlycke agrees to acquire leading wound cleansing manufacturer to consolidate its position as global leader in wound care
Mölnlycke Health Care signed an agreement to acquire P.G.F. Industry Solutions GmbH, the manufacturer of Granudacyn®, a range of solutions for wound...
Mölnlycke is proud to present My Mölnlycke
